1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Demographic and clinical characteristics of participantsa
Patient Characteristics Age (yr) 72.5 (10.0, 45–89) Female 11 (23%) Active smoker 7 (15%) Diabetes mellitus 7 (15%) Hypertension 26 (55%) Hyperlipidemia 20 (43%) Statin use 37 (78%) Aspirin use 29 (61%) Clinical presentation Asymptomatic 23 (49%) TIA 9 (19%) Stroke 15 (32%)
↵a Data are expressed as mean (SD, range) or number of participants (% of 47).